Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron

被引:14
|
作者
Dong, Rui [1 ,2 ]
Hu, Taojun [3 ]
Zhang, Yunjun [3 ]
Li, Yang [4 ]
Zhou, Xiao-Hua [3 ,5 ]
机构
[1] Tsinghua Univ, Yau Math Sci Ctr, Beijing 100084, Peoples R China
[2] Yanqi Lake Beijing Inst Math Sci & Applicat, Beijing 101408, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Biostat, Beijing 100191, Peoples R China
[4] Univ Chinese Acad Sci, Chongqing Sch, Chongqing 400020, Peoples R China
[5] Peking Univ, Beijing Int Ctr Math Res, Beijing 100191, Peoples R China
基金
中国国家自然科学基金; 比尔及梅琳达.盖茨基金会;
关键词
Delta variants; Omicron variants; B.1.617.2; AY.4; BA.1; reproductive number; vaccination; nonpharmaceutical interventions; COVID-19; DYNAMICS;
D O I
10.3390/vaccines10040496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Omicron, the latest SARS-CoV-2 Variant of Concern (VOC), first appeared in Africa in November 2021. At present, the question of whether a new VOC will out-compete the currently predominant variant is important for governments seeking to determine if current surveillance strategies and responses are appropriate and reasonable. Based on both virus genomes and daily-confirmed cases, we compare the additive differences in growth rates and reproductive numbers (R-0) between VOCs and their predominant variants through a Bayesian framework and phylo-dynamics analysis. Faced with different variants, we evaluate the effects of current policies and vaccinations against VOCs and predominant variants. The model also predicts the date on which a VOC may become dominant based on simulation and real data in the early stage. The results suggest that the overall additive difference in growth rates of B.1.617.2 and predominant variants was 0.44 (95% confidence interval, 95% CI: -0.38, 1.25) in February 2021, and that the VOC had a relatively high R-0. The additive difference in the growth rate of BA.1 in the United Kingdom was 6.82 times the difference between Delta and Alpha, and the model successfully predicted the dominating process of Alpha, Delta and Omicron. Current vaccination strategies remain similarly effective against Delta compared to the previous variants. Our model proposes a reliable Bayesian framework to predict the spread trends of VOCs based on early-stage data, and evaluates the effects of public health policies, which may help us better prepare for the upcoming Omicron variant, which is now spreading at an unprecedented speed.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa
    Yu, Yangyang
    Liul, Yuan
    Zhao, Shi
    Hel, Daihai
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2022, 19 (10) : 10361 - 10373
  • [2] Survivability of Delta and Omicron variants of SARS-CoV-2 in wastewater
    Sherchan, Samendra P.
    Thakali, Ocean
    Ikner, Luisa A.
    Gerba, Charles
    Haramoto, Eiji
    WATER RESEARCH, 2023, 246
  • [3] Neuropathological features of SARS-CoV-2 delta and omicron variants
    Normandin, Erica
    Valizadeh, Navid
    Rudmann, Emily A.
    Uddin, Rockib
    Dobbins, Sabrina T.
    MacInnis, Bronwyn L.
    Padera Jr, Robert F.
    Siddle, Katherine J.
    Lemieux, Jacob E.
    Sabeti, Pardis C.
    Mukerji, Shibani S.
    Solomon, Isaac H.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (04): : 283 - 295
  • [4] SARS-CoV-2 dual infection with Delta and Omicron variants in an
    Abroi, Aare
    Talas, Ulvi Gerst
    Pauskar, Merit
    Shablinskaja, Arina
    Reisberg, Tuuli
    Niglas, Heiki
    Pall, Taavi
    Nelis, Mari
    Tagen, Ingrid
    Soodla, Pilleriin
    Lutsar, Irja
    Huik, Kristi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 41 - 44
  • [5] Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
    Earnest, Rebecca
    Uddin, Rockib
    Matluk, Nicholas
    Renzette, Nicholas
    Turbett, Sarah E.
    Siddle, Katherine J.
    Loreth, Christine
    Adams, Gordon
    Tomkins-Tinch, Christopher H.
    Petrone, Mary E.
    Rothman, Jessica E.
    Breban, Mallery, I
    Koch, Robert Tobias
    Billig, Kendall
    Fauver, Joseph R.
    Vogels, Chantal B. F.
    Bilguvar, Kaya
    De Kumar, Bony
    Landry, Marie L.
    Peaper, David R.
    Kelly, Kevin
    Omerza, Greg
    Grieser, Heather
    Meak, Sim
    Martha, John
    Dewey, Hannah B.
    Kales, Susan
    Berenzy, Daniel
    Carpenter-Azevedo, Kristin
    King, Ewa
    Huard, Richard C.
    Novitsky, Vlad
    Howison, Mark
    Darpolor, Josephine
    Manne, Akarsh
    Kantor, Rami
    Smole, Sandra C.
    Brown, Catherine M.
    Fink, Timelia
    Lang, Andrew S.
    Gallagher, Glen R.
    Pitzer, Virginia E.
    Sabeti, Pardis C.
    Gabriel, Stacey
    MacInnis, Bronwyn L.
    Tewhey, Ryan
    Adams, Mark D.
    Park, Daniel J.
    Lemieux, Jacob E.
    Grubaugh, Nathan D.
    CELL REPORTS MEDICINE, 2022, 3 (04)
  • [6] SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
    Keyel, Alexander C.
    Russell, Alexis
    Plitnick, Jonathan
    V. Rowlands, Jemma
    Lamson, Daryl M.
    Rosenberg, Eli
    George, Kirsten St.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (10) : 1990 - 1998
  • [7] Vaccine effectiveness against delta and omicron variants of SARS-CoV-2
    Kundi, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [8] Suppression of the alpha, delta, and omicron variants of SARS-Cov-2 in Taiwan
    Tsou, Hsiao-Hui
    Lee, Fang-Jing
    Wu, Shiow-Ing
    Fan, Byron
    Wu, Hsiao-Yu
    Lin, Yu-Hsuan
    Hsu, Ya-Ting
    Cheng, Chieh
    Cheng, Yu-Chieh
    Jiang, Wei-Ming
    Chiou, Hung-Yi
    Chen, Wei J.
    Hsiung, Chao A.
    Chen, Pau-Chung
    Sytwu, Huey-Kang
    PLOS ONE, 2024, 19 (03):
  • [9] Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
    Chaudhari, Armi M.
    Joshi, Madhvi
    Kumar, Dinesh
    Patel, Amrutlal
    Lokhande, Kiran Bharat
    Krishnan, Anandi
    Hanack, Katja
    Filipek, Slawomir
    Liepmann, Dorian
    Renugopalakrishnan, Venkatesan
    Paulmurugan, Ramasamy
    Joshi, Chaitanya
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 4501 - 4516
  • [10] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836